IPO Boutique Research, Color & More Information for Subscribers
It was a lighter month in terms of quantity of IPOs that came to market in January. Just 13 deals came to market this month as compared to 17 deals that came to market in January 2014. But with what the new issues market lacked in number, it made up for it in quality with[…]
This past week ten IPOs debuted, six updated terms and zero new deals filed. Of the ten deals that came to market, two of them—Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE)—closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs
Flex Pharma (Nasdaq: FLKS) – Flex Pharma upsizes and prices deal above range. Flex prices 5.4 million shares at $16.00. The initial filing stated that they would offer 4.6 million shares at a range of $12-$14. Entellus Medical (Nasdaq: ENTL) – Entellus Medical upsizes IPO and prices at top end of range. The deal was[…]
Tuesday Zosano Pharma (Nasdaq: ZSAN) Wednesday Presbia PLC (Nasdaq: LENS) Thursday Ascendis Pharma A/S (Nasdaq: ASND) Entellus Medical (Nasdaq: ENTL) Flex Pharma (Nasdaq: FLKS) Friday Avinger (Nasdaq: AVGR) Infraredx (Nasdaq: REDX) InfraREIT (NYSE: HIFR) Shake Shack (NYSE: SHAK) Spark Therapeutics (Nasdaq: ONCE) Tracon Pharmaceuticals (Nasdaq: TCON) Subscribe now to get our full research report, IPO[…]
We expected 2015 to be a robust year for IPOs and were somewhat surprised that more deals did not come to market or set terms before MLK Day. However, that surprise was greeted with eight companies releasing official filings to the SEC setting terms for their respective IPOs. Avinger (Nasdaq: AVGR) – Trade Date: Week[…]